SPHDF
Price
$18.40
Change
+$3.65 (+24.75%)
Updated
Jul 28 closing price
Capitalization
229.36M
XRTX
Price
$0.82
Change
+$0.01 (+1.23%)
Updated
Sep 5 closing price
Capitalization
4.04M
Interact to see
Advertisement

SPHDF vs XRTX

Header iconSPHDF vs XRTX Comparison
Open Charts SPHDF vs XRTXBanner chart's image
Santhera Pharmaceuticals Holdings
Price$18.40
Change+$3.65 (+24.75%)
Volume$600
Capitalization229.36M
XORTX Therapeutics
Price$0.82
Change+$0.01 (+1.23%)
Volume$20.19K
Capitalization4.04M
SPHDF vs XRTX Comparison Chart in %
Loading...
SPHDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SPHDF vs. XRTX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SPHDF is a Hold and XRTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (SPHDF: $18.40 vs. XRTX: $0.82)
Brand notoriety: SPHDF and XRTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SPHDF: 124% vs. XRTX: 14%
Market capitalization -- SPHDF: $229.36M vs. XRTX: $4.04M
SPHDF [@Biotechnology] is valued at $229.36M. XRTX’s [@Biotechnology] market capitalization is $4.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SPHDF’s FA Score shows that 1 FA rating(s) are green whileXRTX’s FA Score has 0 green FA rating(s).

  • SPHDF’s FA Score: 1 green, 4 red.
  • XRTX’s FA Score: 0 green, 5 red.
According to our system of comparison, SPHDF is a better buy in the long-term than XRTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SPHDF’s TA Score shows that 2 TA indicator(s) are bullish while XRTX’s TA Score has 4 bullish TA indicator(s).

  • SPHDF’s TA Score: 2 bullish, 1 bearish.
  • XRTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both SPHDF and XRTX are a good buy in the short-term.

Price Growth

SPHDF (@Biotechnology) experienced а 0.00% price change this week, while XRTX (@Biotechnology) price change was +2.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPHDF($229M) has a higher market cap than XRTX($4.04M). XRTX has higher P/E ratio than SPHDF: XRTX (8.00) vs SPHDF (2.53). SPHDF YTD gains are higher at: 95.329 vs. XRTX (-26.965).
SPHDFXRTXSPHDF / XRTX
Capitalization229M4.04M5,664%
EBITDAN/A-3.28M-
Gain YTD95.329-26.965-354%
P/E Ratio2.538.0032%
RevenueN/A0-
Total CashN/A1.06M-
Total DebtN/A80.5K-
FUNDAMENTALS RATINGS
SPHDF vs XRTX: Fundamental Ratings
SPHDF
XRTX
OUTLOOK RATING
1..100
4573
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
40
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3964
P/E GROWTH RATING
1..100
1279
SEASONALITY SCORE
1..100
1990

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XRTX's Valuation (40) in the null industry is in the same range as SPHDF (59). This means that XRTX’s stock grew similarly to SPHDF’s over the last 12 months.

XRTX's Profit vs Risk Rating (100) in the null industry is in the same range as SPHDF (100). This means that XRTX’s stock grew similarly to SPHDF’s over the last 12 months.

XRTX's SMR Rating (98) in the null industry is in the same range as SPHDF (100). This means that XRTX’s stock grew similarly to SPHDF’s over the last 12 months.

SPHDF's Price Growth Rating (39) in the null industry is in the same range as XRTX (64). This means that SPHDF’s stock grew similarly to XRTX’s over the last 12 months.

SPHDF's P/E Growth Rating (12) in the null industry is significantly better than the same rating for XRTX (79). This means that SPHDF’s stock grew significantly faster than XRTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SPHDFXRTX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
33%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
65%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
12%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
14%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
N/A
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
18%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
SPHDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RDY14.340.19
+1.34%
Dr. Reddy's Laboratories Ltd
SBEV1.640.02
+1.23%
Splash Beverage Group
PSBD13.81-0.03
-0.22%
Palmer Square Capital BDC
AORT43.49-0.54
-1.23%
Artivion
ORGN0.52-0.01
-1.26%
Origin Materials

SPHDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPHDF has been closely correlated with TRML. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if SPHDF jumps, then TRML could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPHDF
1D Price
Change %
SPHDF100%
N/A
TRML - SPHDF
78%
Closely correlated
+6.53%
COGT - SPHDF
63%
Loosely correlated
+0.85%
MEOBF - SPHDF
50%
Loosely correlated
N/A
KROS - SPHDF
38%
Loosely correlated
+0.26%
CYTOF - SPHDF
35%
Loosely correlated
N/A
More